Investor insights
Sectors invested in
Funding rounds participated in
$100M sweet spot round size
Most of their 9 investments are in rounds between $43M and $130M
Investor type
Basic info
Industry
Sectors
Investments made
Shoreline Biosciences, Inc. raised $43M on February 7, 2021
Investors: -, Stork Capital S.à.r.l., Commodore Capital, LP, Gilead Capital LP, Logos Global Management, LP and Cormorant Capital
Prometheus Biosciences, Inc. raised $130M on November 9, 2020
Investors: Perceptive Advisors, Eventide Asset Management, Point72 Asset Management, Irving Investors, RTW Investments, LP, Cedars-Sinai and Cormorant Capital
VectivBio AG raised $110M on October 19, 2020
Investors: Versant Ventures, Surveyor Capital, Eventide Asset Management, Novo Holdings, OrbiMed Advisors, Tekla Capital Management and Cormorant Capital
REVOLUTION Medicines raised $100M on July 9, 2019
Investors: Nextech Invest, Casdin Capital, LLC, The Column Group, Vivo Capital, Third Rock Ventures and Cormorant Capital
- raised $62M on April 24, 2019
Investors: Surveyor Capital, Lumira Ventures, Eventide Asset Management, SBI Investment, SNBL USA, Wellington Management, RA Capital Management, L.P., Osage University Partners (OUP) and Cormorant Capital
BridgeBio raised $299M on January 23, 2019
Investors: Aisling Capital, Hercules Capital, Inc., Perceptive Advisors, Viking Global Investors, KKR & Co. Inc. and Cormorant Capital
Cabaletta Bio raised $50M on January 3, 2019
Investors: Adage Capital Management, 5AM Ventures, Redmile Group and Cormorant Capital
CMAB raised $34M on April 2, 2018
Investors: Tigermed, QianHai FoFs, CD Capital and Cormorant Capital
BridgeBio raised $135M on September 13, 2017
Investors: Aisling Capital, Perceptive Advisors, Viking Global Investors, KKR & Co. Inc. and Cormorant Capital